June 2018

June 2018 Issue

Clearside Study Shows Durable Response in DME

By Jerry Helzner, contributing editor

Suprachoroidal CLS-TA effective given quarterly.
Vitrisa Acquires MAKO Trial Data

By Jerry Helzner, contributing editor

The company will run virtual clinical trials to evaluate wet AMD therapies.

Management Options for Dislocated Intraocular Lens

By M. ALI KHAN, MD

Retinal surgeons have more options than ever.
An Update on Intraocular Pressure Elevation

By SEENU M. HARIPRASAD, MD • SOPHIE J. BAKRI, MD

Examining the dexamethasone intravitreal implant across 3 clinical trials.
Retinal Surgery and Corneal Defects

By PETER K. KAISER, MD • CARL D. REGILLO, MD, FACS • THOMAS A. ALBINI, MD • MARGUERITE MCDONALD, MD, FACS • FRANCIS S. MAH, MD

A joint subspecialty roundtable.
Managing Coexisting Anterior and Posterior Conditions

By LOUISE GAGNON, CONTRIBUTING WRITER

Timing is key.
Eales Disease: A Blast From the Past

By NANDINI VENKATESWARAN, MD • SONAL B. DAVE, MD • HARRY W. FLYNN JR., MD

A rare but important disease to consider in patients with vasculitis.
The Comanagement of Uveitis Patients

By ELIZABETH A. ATCHISON, MD • PAULINE T. MERRILL, MD

Track patients along their treatment journey.
Evaluating Retinal Function in Cataract Patients With Full-Field Electroretinography

By WILLIAM I. BOND, MD, FACS

Establish whether the retina is healthy enough to support a premium IOL.
Demystifying Retinal Dystrophies

By NIERAJ JAIN, MD

Clinical pearls in the gene therapy era.

UPFRONT: Premium Services and the Retina

By Peter K. Kaiser, MD
SUBSPECIALTY NEWS: FDA approves first AI device to detect DR, brolucizumab reliable for 12-week dosing, and more.

By JERRY HELZNER, CONTRIBUTING EDITOR
FUTURE FILE: Highlighting innovative early-stage and preclinical concepts in retina

By JERRY HELZNER, CONTRIBUTING EDITOR
NEW PRODUCT APPLICATIONS: On the Cutting Edge of Vitrectomy Surgery

By KAREN APPOLD, CONTRIBUTING WRITER

Bausch + Lomb’s vitrectomy cutters optimize efficiency and provide greater versatility.
CLINICAL TRIAL UPDATE